Oral induction of the insulin hyper-responsiveness in rats with ventromedial hypothalamic lesions. 1980

J Louis-Sylvestre, and C Larue-Achagiotis, and J Le Magnen

Bilateral electrolytic or sham-lesions of the ventromedial nuclei of the hypothalamus (VMH) were performed on fasting (prior to and after the lesion) ether anesthetized rats. Post-operatively (2 hours), sham-operated rats were either offered an oral glucose solution or were submitted to an intravenous glucose injection or were left undisturbed; lesioned rats were offered an oral glucose load or were submitted to an intravenous glucose injection. Three hours later, the insulin response to an intravenous glucose load was tested in all rats. No significant difference could be detected between the results obtained in the three subgroups of sham-operated rats. By contrast, the VMH lesioned rats exhibited a differential response according to the post-lesion treatment. In lesioned rats, given an intravenous glucose injection in the immediate post-lesion period, the tested insulin response was not significantly different from the response of the controls. When lesioned animals were allowed to taste and ingest as little at 0.5 g glucose, the tested insulin response was greatly enhanced. It is concluded that an oral intake is a prerequisite to the induction of the insulin hyper-responsiveness characteristic of fed VMH lesioned rats and that a 0.5 glucose oral intake is sufficient.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

J Louis-Sylvestre, and C Larue-Achagiotis, and J Le Magnen
April 1974, Acta physiologica Scandinavica,
J Louis-Sylvestre, and C Larue-Achagiotis, and J Le Magnen
June 1968, Endocrinology,
J Louis-Sylvestre, and C Larue-Achagiotis, and J Le Magnen
August 1973, Journal of comparative and physiological psychology,
J Louis-Sylvestre, and C Larue-Achagiotis, and J Le Magnen
April 1984, The American journal of physiology,
J Louis-Sylvestre, and C Larue-Achagiotis, and J Le Magnen
April 1984, The American journal of physiology,
J Louis-Sylvestre, and C Larue-Achagiotis, and J Le Magnen
November 1973, Metabolism: clinical and experimental,
J Louis-Sylvestre, and C Larue-Achagiotis, and J Le Magnen
June 1984, Physiology & behavior,
J Louis-Sylvestre, and C Larue-Achagiotis, and J Le Magnen
October 1986, Endocrinology,
J Louis-Sylvestre, and C Larue-Achagiotis, and J Le Magnen
June 1993, Physiology & behavior,
J Louis-Sylvestre, and C Larue-Achagiotis, and J Le Magnen
March 1981, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!